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Background: Coronary artery disease (CAD) and cancer have common risk factors. According to the necessity 
of mass resection in patients with CAD at the same time, we decided to do neck and head mass resection and 
coronary artery bypass grafting (CABG) simultaneously and assess the results. 
Methods: The current study was done on patients who were candidates for simultaneous head and neck mass 
resection and CABG. The patients’ files were extracted, the information and complications were recorded in a 
questionnaire, and then necessary data were extracted. 
Results: Totally 9 patients (3 females and 6 males) with a mean age of 69.11 ± 6.67 standard deviation years 
were studied. The most common site of squamous cell carcinoma in this study was tongue. Infection occurred 
in three patients, two of which (66.66%) died. Side effects occurred in four patients. 
Conclusions: It seems that, according to the anatomical position of neck mass, proximity to the airways and 
large blood supply in that area, and also because of inappropriate access to the anatomical zones, the survival 
rate and complications in this surgical setting (simultaneous surgeries) are different from that of other studies. 
It seems that further studies are needed to be done with the subject of concomitant head and neck mass surgery 
and CABG this time with a larger number of patients. 
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Introduction 
Coronary artery disease (CAD) and cancer are the main 
causes of mortality in many parts of the world (1). CAD 
and cancer have common risk factors such as age, tobacco 
usage, and obesity (2). Other causes can be due to 
outcomes of chemotherapy and radiotherapy in patients 
who had long survival after cancer (3). These treatments 
have a direct side effect on the heart, which require 
surgical correction in some patients. Malignancy may 
occur in the long-term follow-up after coronary artery 
bypass grafting (CABG) (4). The increasing number of 
diagnostic facilities have helped us in the simultaneous 
diagnosis of both cancer and CAD (3,5). Therefore, the 
simultaneous treatment of these two diseases is not 
unusual. The incidence of cancer in some cases of CAD is 
reported to be 1.9-4.2% (4-8). 
There are many cardiotoxic effects of 
chemotherapy (3). The severity of myocardial injury 
depends on the type of chemotherapy and cell changes. 
Some types are irreversible and have permanent effects 
on their left ventricular ejection fraction (EF) (9). 
Arrhythmias, conduction deficiency, pericarditis, and 
other thromboembolic complications are the side 
effects of chemotherapy. The long mediastinal 
radiotherapy affects the coronary arteries and heart 
valves. CAD occurs over a duration of 9 years after 
radiation therapy, it has been increased to 63% (2,10). 
Tumor surgery and CABG can be performed 
simultaneously as one- or two-step procedure. If the 
two-stage procedure is selected, the recovery time must 
be 4-6 weeks (11,12). No study was performed exactly 
similar to our study; the majority of studies about 
CABG and cancer at the same time were associated 
with lung tumors, gastrointestinal (GI) or 
hematological malignancies.  
CABG: Simultaneous Head and Neck Mass Surgery 
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In 2009, another study entitled, “CABG and 
pulmonary resection at the same time” showed that 
surgical treatment in heart and lung diseases 
simultaneously is inconclusive. The study concludes that 
the procedures for heart and lung diseases can be done 
without the morbidity and mortality in the hospital (13). 
Some studies have shown that patients with hematologic 
malignancies frequently need to have major heart 
surgeries and some reports noted an increased risk of 
complications during surgery in these patients (14). The 
results of these studies suggest that cardiac surgery can be 
performed with acceptable mortality but with higher 
morbidity in patients with hematologic malignancy. 
Bleeding and infection are the most common side effects 
that usually lead to further surgery. These findings require 
careful selection of patients (15). 
The major goal of CABG is to reduce cardiac 
complications during or after non-cardiac surgery (2). 
Another goal is to eliminate symptoms if the expected 
survival duration in cancer is more than 6 months (16). 
The last sentence was about gastric cancer but this 
proposition is valid also for other tumor types, which 
has not been studied. Most of the articles are about 
cancers of the lung, GI, and hematologic malignancies, 
and its relation to cardiac surgery, the subject of our 
study, is head and neck cancers, especially squamous 
cell carcinoma (SCC). Head and neck cancers are 
malignant neoplasms in the head which can occur in 
the regions such as the cavity of the nose, paranasal 
sinuses, oral cavity, salivary glands, pharynx, and 
larynx. Therefore, according to the necessity of mass 
resection in patients with CAD at the same time, we 
decided to do neck and head mass resection and CABG 
simultaneously and assess the results. 
 
Materials and Methods 
This case series study was done on patients who were 
candidates for simultaneous head and neck mass 
resection and CABG at Imam Khomeini Hospital 
between 2006 and 2014. Since the study was 
retrospective, there was no need to calculate the sample 
size and all the patients who had simultaneous head 
and neck mass resection and CABG were enrolled. The 
patients’ files were extracted, the informations and 
complications were recorded in a questionnaire, and 
then the necessary data were extracted. 
Then, the patients were followed up face to face or 
on the phone. Statistical analysis was performed using 
SPSS software (version 16, SPSS Inc., Chicago, IL, 
USA). Statistical t-test and chi-square test were used to 
analyze the data. To gain influence over the fate of a 
variable, regression analysis was used.  
 
Results 
9 patients (3 females and 6 males) with a mean age of 
69.11 ± 6.67 standard deviation years were studied. 
The mean age of patients who died was 69.50 ± 5.97 
years and the mean age of living patients was  
68.80 ± 7.89 years (P = 0.664). The mean height of 
patients was 1.67 ± 0.05 m (P = 0.477). The mean 
weight of patients was 67.00 ± 14.11 kg and it was 
72.00 ± 25.45 kg in the living patients and 64.50 ± 9.35 
kg in the patients who died (P = 0.047). 
The average body mass index was 20.11 ± 3.05 kg/m2 
in the living patients and 19.48 ± 2.25 in the patients 
who died (P = 0.386). Two individuals were smokers 
(22.22%) and others were non-smokers (77.77%). 
Based on our results, one of the smoker patients died 
47 months after surgery. The most common site of 
SCC in this study was tongue (55.55%). Nose, neck, 
ear, and larynx had one item each (11.11%). The mean 
pre-operative EF was 14.79% ± 38.33% and the mean 
post-operative EF was 11.70% ± 37.22% (P = 0.744). 
Two patients in our study had undergone chemotherapy 
(22.22%), which has lasted for 5 sessions with 
therapeutic chemistry. 5 patients (55.55%) had undergone 
radiotherapy, with an average of 32.4 sessions. During our 
follow-up, 4 patients died and the average time between 
surgery and death was 16 months (range: 1-47 months). 
Seroma occurred in one patient and this case died 
during the follow-up period. Infection occurred in 3 
patients of which 2 persons (66.66%) died in the 
beginning of follow-up period and one of them was 
admitted to coronary care unit (CCU) and this case also 
died during the follow-up period. Side effects occurred 
in 4 patients; side effects include wound secretion in 
the sternum, recurrence of laryngeal adductor paralysis, 
dysarthria, burning of the tongue, drought, and pain. 
 
Discussion 
This case series study was done to evaluate the results 
of simultaneous head and neck mass resection and 
CABG. In this study, 9 patients (3 females and 6 
males) were studied. Reduced life expectancy may 
discourage some surgeons from necessary coronary 
and valvular surgery in benign neoplasms. On the other 
hand, there is an increasing concern about worsening of 
the cancer due to disorders of the immune system after 
CABG. Application of one- or two-staged surgery, 
time of heparinization, and the necessity of 
cardiorespiratory bypass are controversial. In Fecher  
et al’s. study (15), it was mentioned that patients with 
hematologic malignancies were frequently requiring 
cardiac surgeries. Some reports have indicated an 
increased risk of complication during surgery in 
immunocompromised patients (11). One of the most 
important factors in this study was the survival of the 
patients after concomitant procedures were carried out. 
In our study, the 5-year survival rate was 55.56% and 
there was no in-hospital death. Whereas in the Fecher 
et al’s. study (15), the 3-year survival rate was 83% in 
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patients with hematologic malignancies who had 
simultaneous cardiac surgery. 
In Canver et al’s. study (13) that was done on 
patients with cancers (except dermatological cancers) 
who had a simultaneous cardiac surgery, two death 
occurred; one of them was because of cardiogenic 
shock after the combined exchange of mitral and aortic 
valves and another one was due to pulmonary emboli 
and the 3-4 year survivals reported 95%. Also, the 
quality of life was satisfactory after surgeries. Danton 
et al’s. study (17) that was about concomitant cardiac 
surgery and pulmonary resection did not show any in-
hospital mortality and the 3-year survival rate was 
79%. Infection was detected in three patients (33.33%). 
Two of the three had died. None of the patients had 
hematoma and one case was admitted to the CCU. Side 
effects occurred in four patients, three of the four 
patients had died. Complications in the dead patients 
included sternal wound drainage, recurrent 
lymphadenopathy and dysarthria, dysphagia, and 
burning tongue. Complications in survived patients 
included stiffness and pain in his/her tongue. It seems 
that, according to the anatomical position of neck mass, 
proximity to the airways and large blood supply in that 
area, and also because of inappropriate access to the 
anatomical zones, the survival rate and complications 
in this surgical setting (simultaneous surgeries) are 
different from that of other studies. It seems that 
further studies are needed to be done with the subject 
of concomitant head and neck mass surgery and CABG 
this time with a larger number of patients. More studies 
can lead to more accurate and generable results. 
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